Safety and Efficacy of a tCD25 Preselective Combination Anti‐HIV Lentiviral Vector in Human Hematopoietic Stem and Progenitor Cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1549-4918|33|3|870-879

ISSN: 1066-5099

Source: STEM CELLS, Vol.33, Iss.3, 2015-03, pp. : 870-879

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content